48 related articles for article (PubMed ID: 1490687)
1. Delayed activation of D-glucose transport in type II diabetes mellitus.
Zeuzem S; Jungmann E; Podda M; Schöffling K; Caspary WF
Horm Metab Res Suppl; 1992; 26():22-4. PubMed ID: 1490687
[TBL] [Abstract][Full Text] [Related]
2. In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus.
Kashiwagi A; Verso MA; Andrews J; Vasquez B; Reaven G; Foley JE
J Clin Invest; 1983 Oct; 72(4):1246-54. PubMed ID: 6355180
[TBL] [Abstract][Full Text] [Related]
3. Comparison of alterations in insulin signalling pathway in adipocytes from Type II diabetic pregnant women and women with gestational diabetes mellitus.
Tomazic M; Janez A; Sketelj A; Kocijancic A; Eckel J; Sharma PM
Diabetologia; 2002 Apr; 45(4):502-8. PubMed ID: 12032625
[TBL] [Abstract][Full Text] [Related]
4. Hexose transport regulation in cultured fibroblasts derived from normal and type II diabetic patients.
Germinario RJ; Oliveira M; Manuel S; Taylor M
Clin Invest Med; 1987 Jul; 10(4):295-302. PubMed ID: 3308239
[TBL] [Abstract][Full Text] [Related]
5. Improvement in in vitro insulin action after one month of insulin therapy in obese noninsulin-dependent diabetics. Measurements of glucose transport and metabolism, insulin binding, and lipolysis in isolated adipocytes.
Foley JE; Kashiwagi A; Verso MA; Reaven G; Andrews J
J Clin Invest; 1983 Dec; 72(6):1901-9. PubMed ID: 6358258
[TBL] [Abstract][Full Text] [Related]
6. Glucose transport and metabolism in adipocytes from newly diagnosed untreated insulin-dependent diabetics. Severely impaired basal and postinsulin binding activities.
Hjøllund E; Pedersen O; Richelsen B; Beck-Nielsen H; Sørensen NS
J Clin Invest; 1985 Dec; 76(6):2091-6. PubMed ID: 4077975
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence for a stimulatory effect of hyperglycemia per se on peripheral glucose disposal in type II diabetes.
Capaldo B; Santoro D; Riccardi G; Perrotti N; Saccà L
J Clin Invest; 1986 Apr; 77(4):1285-90. PubMed ID: 2870077
[TBL] [Abstract][Full Text] [Related]
8. Glucose transport into skeletal muscle. Influence of contractile activity, insulin, catecholamines and diabetes mellitus.
Wallberg-Henriksson H
Acta Physiol Scand Suppl; 1987; 564():1-80. PubMed ID: 2890259
[TBL] [Abstract][Full Text] [Related]
9. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?
Burén J; Lindmark S; Renström F; Eriksson JW
Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640
[TBL] [Abstract][Full Text] [Related]
10. Effects of NIDDM on the glucose transport system in human skeletal muscle.
Scheck SH; Barnard RJ; Lawani LO; Youngren JF; Martin DA; Singh R
Diabetes Res; 1991 Mar; 16(3):111-9. PubMed ID: 1802477
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
Toft I; Jenssen T
Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
[TBL] [Abstract][Full Text] [Related]
12. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
[TBL] [Abstract][Full Text] [Related]
13. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
Vaag A; Skött P; Damsbo P; Gall MA; Richter EA; Beck-Nielsen H
J Clin Invest; 1991 Oct; 88(4):1282-90. PubMed ID: 1918378
[TBL] [Abstract][Full Text] [Related]
14. Reduced glucose effectiveness as a feature of glucose intolerance: evidence in elderly type-2 diabetic subjects.
Viviani GL; Pacini G
Aging (Milano); 1999 Jun; 11(3):169-75. PubMed ID: 10476312
[TBL] [Abstract][Full Text] [Related]
15. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes.
Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS
Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067
[TBL] [Abstract][Full Text] [Related]
16. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
[TBL] [Abstract][Full Text] [Related]
17. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
[TBL] [Abstract][Full Text] [Related]
18. [Role of amylin in the pathogenesis of type II diabetes mellitus].
Prager R; Ludvik B; Hartter E
Acta Med Austriaca; 1991; 18(3):61-2. PubMed ID: 1950379
[TBL] [Abstract][Full Text] [Related]
19. Glucose transport in human peripheral blood lymphocytes influenced by type 2 diabetes mellitus.
Piatkiewicz P; Czech A; Tatoń J
Arch Immunol Ther Exp (Warsz); 2007; 55(2):119-26. PubMed ID: 17417692
[TBL] [Abstract][Full Text] [Related]
20. Factors in serum from type 2 diabetes patients can cause cellular insulin resistance.
Renström F; Burén J; Svensson MK; Eriksson JW
Horm Metab Res; 2009 Oct; 41(10):767-72. PubMed ID: 19764108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
